Bonus Material-03_Viral_Fungi_NocActin_Pulm_infx_2025_FINAL

Pdf Summary

This comprehensive lecture by Dr. Marcos I. Restrepo provides an in-depth overview of major pulmonary infections caused by viral, fungal, and less common bacterial pathogens. It focuses on respiratory viruses such as influenza, respiratory syncytial virus (RSV), SARS-CoV-2, cytomegalovirus (CMV), herpes simplex virus (HSV), and varicella-zoster virus (VZV), emphasizing their epidemiology, clinical impact, diagnostic methods, treatments, and prevention strategies, including vaccination protocols. For influenza, the lecture details virus types, transmission, diagnostic tests, antivirals (neuraminidase inhibitors, baloxavir), and yearly vaccine recommendations.<br /><br />The fungal infections section covers pulmonary diseases caused by Aspergillus species (including invasive pulmonary aspergillosis and chronic cavitary pulmonary aspergillosis), mucormycosis, candidiasis, blastomycosis, coccidioidomycosis, histoplasmosis, pneumocystis pneumonia (PCP), and cryptococcosis. It describes pathogen characteristics, risk factors (immunosuppression, chronic lung disease), clinical presentations, diagnostic approaches (culture, antigen tests, imaging), and treatment modalities such as antifungals (voriconazole, amphotericin B, isavuconazole) and surgical options.<br /><br />The less common bacterial infections focus on Nocardia and Actinomyces species. Nocardia infections typically occur in immunocompromised hosts causing pneumonia and abscesses, diagnosed by staining and culture, with treatment involving prolonged TMP-SMX and combination antibiotics for severe cases. Actinomyces infections are subacute, often polymicrobial, affecting immunocompetent individuals with risk factors like poor dentition, treated with prolonged high-dose penicillin.<br /><br />Key clinical considerations include timely diagnosis and treatment initiation, risk factor identification, and integration of prevention measures such as vaccination for viral infections and management of immunosuppression for fungal and bacterial diseases. The lecture highlights emerging therapies, diagnostic advancements, and management guidelines from authoritative sources, providing a broad yet detailed resource on pulmonary infectious diseases.

Meta Tag

Concept Influenza

Concept Severe Acute Respiratory Syndrome Coronavirus 2

Concept Aspergillus

Concept Pulmonary Infection

Concept Respiratory Syncytial Virus

Keywords

pulmonary infections

respiratory viruses

influenza

RSV

SARS-CoV-2

fungal lung infections

Aspergillus

pneumocystis pneumonia

Nocardia

Actinomyces

Influenza

Severe Acute Respiratory Syndrome Coronavirus 2

Aspergillus

Pulmonary Infection

Respiratory Syncytial Virus